Body mass index as a tool for optimizing surgical care in coronary artery bypass grafting through understanding risks of specific complications.


Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 26 06 2018
revised: 17 06 2019
accepted: 12 07 2019
pubmed: 14 12 2019
medline: 4 8 2020
entrez: 14 12 2019
Statut: ppublish

Résumé

To investigate the relationship between body mass index (BMI) and early outcomes, and specific types of morbidities associated with low and high BMI, in patients undergoing coronary artery bypass grafting. This was a retrospective study on isolated coronary artery bypass grafting patients (aged ≥60 years) between 2008 and 2017 in the Japan Cardiovascular Surgery Database. The primary end point was defined as operative mortality. The secondary end point was combined morbidity (ie, operative mortality, reoperation for bleeding, stroke, new onset of hemodialysis, mediastinitis, and prolonged ventilation). Patient characteristics and outcomes were compared among BMI groups. Spline curves were fit between BMI and outcomes. Multivariable logistic regression models with categorized BMI and generalized additive models with spline-transformed BMI were used to estimate and visualize the effect of BMI adjusted for other covariates. A total of 96,058 patients were included in the analysis. Low (<18.5) and high (≥30) BMI were both associated with a higher risk of mortality (low: adjusted odds ratio, 1.34; 95% confidence interval, 1.16-1.54; P < .0001, and high: adjusted odds ratio, 2.10; 95% confidence interval, 1.70-2.59; P < .0001) and combined morbidity (low: adjusted odds ratio, 1.18; 95% confidence interval, 1.08-1.29; P = .0002 and high: adjusted odds ratio, 1.82; 95% confidence interval, 1.63-2.03; P < .0001). Low and high BMI were associated with different types of morbidities. In models using spline transformation, the deviation of BMI from a proximately 21 to 23 was proportionally associated with increased risk. In patients undergoing coronary artery bypass grafting, low and high BMI were risk factors of mortality associated with different types of morbidities, which may warrant tailored preventive approaches.

Identifiants

pubmed: 31831196
pii: S0022-5223(19)31513-2
doi: 10.1016/j.jtcvs.2019.07.048
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

409-420.e14

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Naritomo Nishioka (N)

Department of Cardiac Surgery, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.

Nao Ichihara (N)

Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.

Ko Bando (K)

Department of Cardiac Surgery, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan. Electronic address: kobando@jikei.ac.jp.

Noboru Motomura (N)

Japan Cardiovascular Surgery Database-Adult Section.

Nobuya Koyama (N)

Japan Cardiovascular Surgery Database-Adult Section.

Hiroaki Miyata (H)

Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan; Japan Cardiovascular Surgery Database-Adult Section; Department of Health Policy and Management, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.

Shun Kohsaka (S)

Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan; Department of Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.

Shinichi Takamoto (S)

Japan Cardiovascular Surgery Database-Adult Section.

Kazuhiro Hashimoto (K)

Department of Cardiac Surgery, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH